Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

3.24
Delayed Data
As of Aug 04
 +0.04 / +1.25%
Today’s Change
0.66
Today|||52-Week Range
3.38
+264.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$116.4M

Company Description

Oragenics, Inc. is a biopharmaceutical company, which is focused on oral probiotics products and novel antibiotics for humans and companion pets. It also develops, markets and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Contact Information

Oragenics, Inc.
4902 Eisenhower boulevard
Tampa Florida 33634
P:(813) 286-7900
Investor Relations:

Employees

Shareholders

Other institutional9.30%
Individual stakeholders46.06%
Mutual fund holders3.70%

Top Executives

Michael O'Keefe SullivanCEO, CFO, Secretary & Treasurer
Martin HandfieldSenior Vice President-Discovery Research
Albert G. FosmoeSenior VP-Operations & Product Development
Guojun NieDirector-Process Development